Doxorubicin Global Industry Report 2025 - Doxorubicin Market Projected to Reach US$1.7 Billion by 2030 [Yahoo! Finance]
Imunon, Inc. (IMNN)
Company Research
Source: Yahoo! Finance
Mon, February 10, 2025 at 12:28 PM GMT+1 7 min read Company Logo Significant growth trajectory of the Breast Cancer Application segment, which is expected to reach US$374.1 Million by 2030 with a CAGR of a 5.6%. The Lung Cancer Application segment is also set to grow at 7.4% CAGR over the analysis period. Doxorubicin Market Doxorubicin Market Dublin, Feb. 10, 2025 (GLOBE NEWSWIRE) -- The "Doxorubicin - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Doxorubicin was valued at US$1.2 Billion in 2024 and is projected to reach US$1.7 Billion by 2030, growing at a CAGR of 5.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers and forecasts. Global Doxorubicin Market - Key Trends & Drivers Summarized Doxorubicin is a potent chemotherapy drug commonly used to treat various types of cancer, including breast cancer, bladder cancer, Kaposi's sarcoma, lymphoma, and a
Show less
Read more
Impact Snapshot
Event Time:
IMNN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMNN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMNN alerts
High impacting Imunon, Inc. news events
Weekly update
A roundup of the hottest topics
IMNN
News
- IMNN: R&D Day Highlights Potential for IMNN-001… [Yahoo! Finance]Yahoo! Finance
- IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- IMUNON Reports Third Quarter 2025 Financial Results and Provides Business UpdateGlobeNewswire
- Imunon Q3 2025 Earnings Preview [Seeking Alpha]Seeking Alpha
- Imunon, Inc. (IMNN) Discusses IMNN-001 Immunotherapy Progress and Milestones in OVATION 3 Ovarian Cancer Study Transcript [Seeking Alpha]Seeking Alpha
IMNN
Sec Filings
- 11/13/25 - Form S-8
- 11/13/25 - Form 10-Q
- 11/13/25 - Form 8-K
- IMNN's page on the SEC website